Open-Label Randomized Controlled Trial to Assess the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision Through Family Planning Services in KwaZulu-Natal, South Africa

Trial Profile

Open-Label Randomized Controlled Trial to Assess the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision Through Family Planning Services in KwaZulu-Natal, South Africa

Completed
Phase of Trial: Phase II/III

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 26 Jul 2017 Results (n=133) assessing potential immune mechanism for the relationship between HIV risk and multiple concurrent HPV infections presented at the 9th International AIDS Society Conference on HIV Science
    • 27 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 27 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top